Clinical Trial Site

Basel 4051

1 studies enrolling now · 4 studies all time

What they study most

ANCA-Associated Vasculitis, Atypical Hemolytic-Uremic Syndrome, High Cardiovascular Risk, Hypertension, Transthyretin Amyloidosis With Cardiomyopathy

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed